Acinetobacter baumannii is undoubtedly one of the most successful pathogens responsible
for hospital-acquired nosocomial infections in the modern healthcare system. Due to the …

Acinetobacter baumannii infections have become an emerging health concern in hospitals
across the world and are often associated with nosocomial infections with poorer clinical …

Antimicrobial combinations are at the moment the only potential treatment option for
pandrug-resistant A. baumannii. A systematic review was conducted in PubMed and Scopus …

Abstract Background Infections caused by Acinetobacter baumannii were responsive to
conventional antibiotic therapy. However, recently, carbapenem-associated multidrug …

Abstract Purpose of Review Acinetobacter baumannii (AB) is an infamous nosocomial
pathogen with a seemingly limitless capacity for antimicrobial resistance, leading to few …

Purpose Pending approval of new antimicrobials, synergistic combinations are the only
treatment option against pandrug-resistant A. baumannii (PDRAB). Considering the lack of a …

Abstract Aims Carbapenem‐resistant Acinetobacter baumannii represents a public health
problem, and the search for new antibacterial drugs has become a priority. Here, we …

Objective: Burn wound infection is a severe complication of thermal injury. Patients with
severe burn injuries need urgent care to diminish complications after severe burns. Wound …

Acinetobacter baumannii (AB) is one of the most notorious and opportunistic pathogens,
which caused high morbidity and mortality rate and World Health Organization (WHO) …

Acinetobacter baumannii remains a difficult-to-treat pathogen that poses a significant
challenge to clinicians and costs to the healthcare system. There is a lack of clinical efficacy …